Fundraising FoxIsrael Biotech Fund — 2017 Investments
2 investments dated 2017 · listed companies and verified rows first · show all
Galmed is a pharmaceutical company developing metabolic and inflammatory therapeutic drugs through discovery and clinical trial phases.
BiotechTel Aviv
Allen Baharaff(Executive Officer, Director)Tali Gorfine(Executive Officer)Yohai Stenzler(Executive Officer)inLiat Hayardeny(Executive Officer)in
BoardChaim Hurvitz(Director)
Board seatDavid Sidransky· per SEC Form D · $350K raise · filed Aug 2017
Ukko develops immuno-therapeutics for life-threatening food allergies using a computational protein design platform.
AI & Machine LearningBiotechDigital HealthMountain View, US
Anat Binur(Founder)inYanay Ofran(Founder)inJudith Weiss Paltiel(PhD, VP Development)in
BoardScott Brady(Director)Samir Kaul(Director)in
Co-investorsKhosla VenturesSanara CapitalWestern Technology InvestmentFall Line CapitalLeaps by BayerPeakBridge VC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.